7 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Identification of 2-[2-(4-tert-butylphenyl)ethyl]-N-(4-fluorophenyl)-1,2,3,4-tetrahydroisoquinoline-6-sulfonamide (29) as an orally available MGAT2 inhibitor.
Taisho Pharmaceutical
MoGAT-2 Inhibitors May Provide Effective Treatment for Hypertriglyceridemia.
Therachem Research Medilab (India)
Fighting Obesity and Metabolic Disorders with MGAT-2 Inhibitors.
Therachem Research Medilab (India)
Discovery of novel pyridinones as MGAT2 inhibitors for the treatment of metabolic disorders.
Bristol Myers Squibb
Substituted pyrazolyl[4,3-c]pyridine compounds as RET kinase inhibitors
Array Biopharma